A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty

Journal of the American College of Cardiology

Volumn 29, Issue 7, 1997, Pages 1459-1467

  Stone, Gregg W ^a   Marsalese, Dominic ^b   Brodie, Bruce R ^c   Griffin, John J ^d   Donohue, Bryan ^e   Costantini, Costantino ^f   Balestrini, Carlos ^g   Wharton, Thomas ^h   Esente, Paolo ⁱ   Spain, Michael ^j   Moses, Jeffrey ^k   Nobuyoshi, Masakiyo ^l   Ayres, Mike ^m   Jones, Denise ^b   Mason, Denise ^b   Grines, Lorelei ^b   O'Neill, William W ^b   Grines, Cindy L ^b  

^a EL CAMINO HOSPITAL   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c MOSES H CONE MEMORIAL HOSPITAL   (United States)

^d Sentara Virginia Beach General Hospital   (United States)

^e ALLEGHENY GENERAL HOSPITAL   (United States)

^f Hospital Santa Case de Misericordia   (Brazil)

^g Instituto Modelo de Cardiologia   (Argentina)

^h Division of Cardiology   (United States)

ⁱ St Joseph's Hospital   (United States)

^j Saint Francis Hospital Tulsa   (United States)

^k LENOX HILL HOSPITAL   (United States)

^l KOKURA MEMORIAL HOSPITAL   (Japan)

^m Fort Sanders Regional Medical Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNTERPULSATION; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART REINFARCTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; HEMORRHAGE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0003849494     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00088-0     Document Type: Article

References (49)

1. Grines CL, Browne KR, Marco J, et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
2. Zijlstra F, DeBoer MJ, Hoorntje JCA, Reiffer S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
3. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 328:1993;685-691.
4. Michels KB, Yusif S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative (meta-analysis) of the randomized clinical trials . Circulation. 91:1995;476-485.
5. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and six month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 25:1995;370-377.
6. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
7. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 2:1988;349-360.
8. Wilcox RG, Olsson CG, Skene AM, Von Der Lippe G, Jensen G, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction AngloScandinavian Study of Early Thrombolysis (ASSET) . Lancet. 2:1988;525-530.
9. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction results from an international trial of 41,021 patients . Circulation. 91:1995;1659-1668.
10. Volpi A, De Vita C, Franzosi MG, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis results of the GISSI-2 data base . Circulation. 88:1993;416-429.
11. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) trial, Phase 1 findings . N Engl J Med. 320:1989;618-627.
12. An international randomized trial comparing four thrombolytic regimens consisting of tissue plasminogen activator, streptokinase, or both for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
13. Appleby P, Baigent C, Collins R, Flather M, Parish S, Peto R. Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients . Lancet. 343:1994;311-322.
14. O'Keefe JO, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol. 72:1993;107G-115G.
15. Ishihara M, Sato H, Tateishi H, Uchida Toshiaki, Dote K. Intraaortic balloon pumping as the post angioplasty strategy in acute myocardial infarction. Am Heart J. 122:1991;385-389.
16. Ohman EM, Califf RM, George BS, et al. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J. 191:1991;895-901.
17. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction results of a randomized trial . Circulation. 90:1994;792-799.
18. Ishihara M, Sato H, Tateishi H, et al. Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall myocardial infarction. Am J Cardiol. 76:1995;73-75.
19. Grines CL, Schreiber TL, Savas V, et al. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 27:1996;1381-1386.
20. Piessens JH, Stammen F, Vrolix MC, et al. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cathet Cardiovasc Diagn. 28:1993;99-105.
21. Brodie B, Grines CL, Spain S, et al. A prospective, randomized trial evaluating early discharge (day 3) without non-invasive risk stratification in low risk patients with acute myocardial infarction PAMI-2 . J Am Coll Cardiol. 25:(Suppl A):1995;430A.
22. Smith AJC, Holt RE, Fitzpatrick K, et al. Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty. Am Heart J. 131:1996;434-439.
23. The Thrombolysis in Myocardial Infarction (TIMI) trial Phase 1 findings . N Engl J Med. 312:1985;932-936.
24. Dodge HT, Sandler H, Ballew DW, Lord JD. The use of biplane angiography for the measurement of left ventricular volume in man. Am Heart J. 60:1960;762-766.
25. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline chord method for characterizing regional ventricular function. Circulation. 74:1986;293-305.
26. Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction a 3 year experience . J Am Coll Cardiol. 10:1987;264-272.
27. Miller PF, Brodie BR, Weintraub RA, LeBauer J, Katz JD, Stuckey TD. Emergency coronary angioplasty for acute myocardial infarction. Arch Intern Med. 147:1987;1565-1570.
28. O'Keefe JH, Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 64:1989;1221-1230.
29. Stone GW, Rutherford BD, McConahay DR, et al. Direct coronary angioplasty in acute myocardial infarction outcome in patients with single vessel disease . J Am Coll Cardiol. 15:1990;534-543.
30. Ellis SG, Gallison L, Grines CL, et al. Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 64:1989;263-268.
31. Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
32. Kern MJ, Aguirre F, Bach R, Donohue T, Siegal R, Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation. 87:1993;500-511.
33. Gurbel PA, Anderson RD, MacCord CS, et al. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary reperfusion by thrombolytic therapy. Circulation. 89:1994;361-365.
34. Kern MJ, Aguirre FV, Tatineni S, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 21:1993;359-368.
35. Smalling RW, Cassidy DB, Barrett R, Lachterman B, Felli P, Amirian J. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. Circulation. 85:1992;1152-1159.
36. Grines C, Marsalese D, Brodie B, et al. Acute cath provides the best method of risk stratifying MI patients. Circulation. 92 Suppl I:1995;I-531.
37. Alderman JD, Gabliani GI, McCabe CH, et al. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol. 9:1987;524-530.
38. Goldberger M, Tabak SW, Shah PK. Clinical experience with intra-aortic balloon counterpulsation in 112 consecutive patients. Am Heart J. 111:1986;497-502.
39. Kantrowitz A, Wasfie T, Freef PS, Rubenfire M, Wajszczuk W, Schork MA. Intraaortic balloon pumping 1967 through 1982 analysis of complications in 733 patients . Am J Cardiol. 57:1986;976-983.
40. Ellis SG, Van de Weft F, Riberio-DaSilva E, Topol EJ. Present status of rescue coronary angioplasty current polarization of opinion and randomized trials . J Am Coll Cardiol. 19:1992;681-686.
41. O'Neill WW, Weintraub R, Grines CL, Meany TB, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 86:1992;1710-1717.
42. Ferguson J, Dougherty K, Gaos C, Bush HS, Marsh KC, Leachman DR. Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 23:1994;1061-1065.
43. Badger RS, Brown BG, Kennedy JW, et al. Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year. Am J Cardiol. 59:1987;519-522.
44. Sheehan FH, Mathey DG, Schoffer J, Dodge HT, Bolson EL. Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction. Circulation. 71:1985;1121-1128.
45. Harrison DG, Ferguson DW, Collins SM, et al. Rethrombosis after reperfusion with streptokinase importance of geometry of residual lesions . Circulation. 69:1984;991-999.
46. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
47. O'Neill W, Griffin J, Stone G, et al. Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy. J Am Coll Cardiol. 27 Suppl A:1996;13A.
48. Brodie B, Stuckey T, Weintraub R, et al. Timing and mechanism of death after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 25 Suppl A:1995;47A.
49. Stone GW. Primary PTCA in high risk patients with acute myocardial infarction. J Invasive Cardiol. 7:1995;12F-21F.